FDA Investigating Delaware Heparin Deaths
The Food and Drug Administration is investigating the death of two Delaware hospital patients who were given the blood thinner heparin.
Officials at Beebe Medical Center in Lewes said three patients suffered adverse reactions after being given the drug last week. Two of the patients, a 71-year-old man and a 64-year-old woman, died over the weekend.
An FDA spokeswoman said the agency is working with the hospital and Baxter Healthcare Corp., provider of the drug, to determine what happened.
Copyright 2026 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Popular Today
- Florida Bans Flock Cameras, License Plate Readers From State Roads
- Powerful El Niño Nears Record Strength, US Forecasters Say
- Federal Judge Cautions State Farm Against Gambling With Courts
- The Great Hemp Reset: How the Federal Ban on Intoxicating Hemp Products Will Reshape Risk and Coverage
Popular This Month